NPM1 Gene Mutation Quantitative MRD Monitor Test sale cost 940 AED
Epstein-Barr Virus Early RNA EBER-ISH In-Situ-Hybridization Test sale cost 970 AED Epstein-Barr Virus Early RNA EBER-ISH In-Situ-Hybridization Test Cost 1,080 د.إ Original price was: 1,080 د.إ.970 د.إCurrent price is: 970 د.إ.
Immunophenotyping by Flow Cytometry CD16 and 56 Test sale cost 910 AED Immunophenotyping by Flow Cytometry CD16 and 56 Test Cost 1,010 د.إ Original price was: 1,010 د.إ.910 د.إCurrent price is: 910 د.إ.
Sale!

NPM1 Gene Mutation Quantitative MRD Monitor Test Cost

Original price was: 1,040 د.إ.Current price is: 940 د.إ.

-10%

The NPM1 Gene Mutation Quantitative MRD (Minimal Residual Disease) Monitor Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect and quantify the presence of mutations in the NPM1 gene. This gene is critical for proper cell function, and mutations within it are often associated with certain types of leukemia, notably Acute Myeloid Leukemia (AML). By precisely measuring the amount of mutated NPM1 gene in a patient’s blood or bone marrow, this test plays a crucial role in assessing the effectiveness of treatment, predicting relapse, and guiding therapeutic decisions.

The process involves collecting a sample from the patient, which is then analyzed using advanced genetic sequencing techniques to identify and quantify NPM1 mutations. This test is particularly valuable for monitoring disease progression or remission in patients diagnosed with AML, enabling personalized treatment plans based on the specific genetic profile of the disease.

At DNA Labs UAE, the cost of the NPM1 Gene Mutation Quantitative MRD Monitor Test is set at 940 AED. This price reflects the sophisticated nature of the testing process and the invaluable insights it provides for managing and treating patients with AML. By offering this test, DNA Labs UAE contributes significantly to the personalized and precise treatment of leukemia, improving outcomes for patients with NPM1 gene mutations.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

NPM1 GENE MUTATION QUANTITATIVE MRD MONITOR Test

Test Cost: AED 940.0

Test Name: NPM1 GENE MUTATION QUANTITATIVE MRD MONITOR Test

Components:

  • Price: 940.0 AED
  • Sample Condition: 5 mL (3 mL min.) whole blood / Bone marrow in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.
  • Duly filled MRD Requisition form (Form 22) with historical data is mandatory.

Report Delivery: SampleMon / Thu by 11 am; Report Wed / Sat

Method: Real Time PCR

Test Type: Leukemia

Doctor: Hematologist, Oncologist

Test Department: MOLECULAR DIAGNOSTICS

Pre Test Information: Duly filled MRD Requisition form (Form 22) with historical data is mandatory.

Test Details

The NPM1 gene mutation quantitative MRD monitor test is a diagnostic tool used to monitor minimal residual disease (MRD) in patients with acute myeloid leukemia (AML) who have a mutation in the NPM1 gene.

The NPM1 gene mutation is a common genetic abnormality found in approximately 30% of AML cases. It is associated with a favorable prognosis and is often used as a marker for MRD monitoring.

MRD refers to the small number of cancer cells that may remain in a patient’s body after treatment, even when no cancer cells are detectable by standard tests. Monitoring MRD is important as it can help assess the effectiveness of treatment and predict the likelihood of relapse.

The NPM1 gene mutation quantitative MRD monitor test uses molecular techniques to detect and quantify the presence of NPM1 gene mutations in a patient’s blood or bone marrow samples. It can provide a more sensitive and accurate assessment of MRD compared to traditional methods.

By monitoring the levels of NPM1 gene mutations over time, the test can help clinicians determine if a patient is responding to treatment or if there is a risk of relapse. This information can guide treatment decisions and potentially improve patient outcomes.

Overall, the NPM1 gene mutation quantitative MRD monitor test is a valuable tool in the management of AML patients with NPM1 gene mutations, providing important information for treatment planning and monitoring disease progression.

Test Name NPM1 GENE MUTATION QUANTITATIVE MRD MONITOR Test
Components
Price 940.0 AED
Sample Condition 5 mL (3 mL min.) whole blood \/ Bone marrow in 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled MRD Requisition form (Form 22) with historical data is mandatory.
Report Delivery SampleMon / Thu by 11 am; Report Wed / Sat
Method Real Time PCR
Test type Leukemia
Doctor Hematologist, Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled MRD Requisition form (Form 22) with historical data is mandatory.
Test Details

The NPM1 gene mutation quantitative MRD monitor test is a diagnostic tool used to monitor minimal residual disease (MRD) in patients with acute myeloid leukemia (AML) who have a mutation in the NPM1 gene.

The NPM1 gene mutation is a common genetic abnormality found in approximately 30% of AML cases. It is associated with a favorable prognosis and is often used as a marker for MRD monitoring.

MRD refers to the small number of cancer cells that may remain in a patient’s body after treatment, even when no cancer cells are detectable by standard tests. Monitoring MRD is important as it can help assess the effectiveness of treatment and predict the likelihood of relapse.

The NPM1 gene mutation quantitative MRD monitor test uses molecular techniques to detect and quantify the presence of NPM1 gene mutations in a patient’s blood or bone marrow samples. It can provide a more sensitive and accurate assessment of MRD compared to traditional methods.

By monitoring the levels of NPM1 gene mutations over time, the test can help clinicians determine if a patient is responding to treatment or if there is a risk of relapse. This information can guide treatment decisions and potentially improve patient outcomes.

Overall, the NPM1 gene mutation quantitative MRD monitor test is a valuable tool in the management of AML patients with NPM1 gene mutations, providing important information for treatment planning and monitoring disease progression.

SKU: TEST-5899 Category:

Related products